FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2603502286> ?p ?o ?g. }

• W2603502286 endingPage "58" @default.
• W2603502286 startingPage "51" @default.
• W2603502286 abstract "Aim To compare the efficacy and safety of edoxaban and warfarin for treatment of portal vein thrombosis (PVT) following danaparoid sodium in patients with liver cirrhosis. Methods Fifty cirrhotic patients with PVT treated initially for 2 weeks with danaparoid sodium were enrolled in this retrospective cohort study. Treatment was later switched to either edoxaban (n = 20) or warfarin (n = 30). We compared the efficacy and safety of edoxaban and warfarin for up to 6 months. The PVT volume was measured by dynamic computed tomography before treatment, at 2 weeks, and at 1, 3, and 6 months. Results There were no significant differences in the clinical characteristics of patients in the two groups. Treatment with edoxaban reduced the volume of PVT from 1.42 cm3 at 2 weeks to 0.42 cm3 at 6 months, and prevented exacerbation of PVT at 6 months after treatment with danaparoid sodium (P = 0.016). In contrast, treatment with warfarin resulted in increased PVT volume from 1.73 cm3 at 2 weeks to 2.85 cm3 at 6 months, despite the control of the international normalized ratio in 57% of the patients (P = 0.005). Multivariate regression analysis identified edoxaban therapy as the single significant and independent determinant of PVT reduction at 6 months (P = 0.0014, hazard ratio 6.400). Clinically significant gastrointestinal bleeding was encountered in 3 of 20 (15%) patients of the edoxaban group and 2 of 30 (7%) of the warfarin group (P = 0.335). Conclusion Edoxaban following danaparoid sodium is an effective anticoagulant and could be potentially considered as one of the treatment options for PVT in cirrhotic patients." @default.
• W2603502286 created "2017-04-07" @default.
• W2603502286 creator A5004807660 @default.
• W2603502286 creator A5018431544 @default.
• W2603502286 creator A5019195799 @default.
• W2603502286 creator A5022484621 @default.
• W2603502286 creator A5023958825 @default.
• W2603502286 creator A5024182187 @default.
• W2603502286 creator A5027196488 @default.
• W2603502286 creator A5027695992 @default.
• W2603502286 creator A5031469873 @default.
• W2603502286 creator A5035029873 @default.
• W2603502286 creator A5055874956 @default.
• W2603502286 creator A5060490064 @default.
• W2603502286 creator A5068157865 @default.
• W2603502286 creator A5070035943 @default.
• W2603502286 creator A5074699709 @default.
• W2603502286 creator A5081646000 @default.
• W2603502286 date "2017-04-27" @default.
• W2603502286 modified "2023-10-03" @default.
• W2603502286 title "Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis" @default.
• W2603502286 cites W1528561544 @default.
• W2603502286 cites W1986963195 @default.
• W2603502286 cites W1987880263 @default.
• W2603502286 cites W1992235530 @default.
• W2603502286 cites W1993340951 @default.
• W2603502286 cites W2004096813 @default.
• W2603502286 cites W2004802159 @default.
• W2603502286 cites W2017709949 @default.
• W2603502286 cites W2019035181 @default.
• W2603502286 cites W2027735039 @default.
• W2603502286 cites W2032537572 @default.
• W2603502286 cites W2040826870 @default.
• W2603502286 cites W2048441761 @default.
• W2603502286 cites W2085416230 @default.
• W2603502286 cites W2086955790 @default.
• W2603502286 cites W2096246254 @default.
• W2603502286 cites W2113298609 @default.
• W2603502286 cites W2114958842 @default.
• W2603502286 cites W2115273341 @default.
• W2603502286 cites W2135361119 @default.
• W2603502286 cites W2138045092 @default.
• W2603502286 cites W2139398552 @default.
• W2603502286 cites W2149706443 @default.
• W2603502286 cites W2152623033 @default.
• W2603502286 cites W2158268405 @default.
• W2603502286 cites W2160625453 @default.
• W2603502286 cites W2161090555 @default.
• W2603502286 cites W2172060670 @default.
• W2603502286 doi "https://doi.org/10.1111/hepr.12895" @default.
• W2603502286 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28342265" @default.
• W2603502286 hasPublicationYear "2017" @default.
• W2603502286 type Work @default.
• W2603502286 sameAs 2603502286 @default.
• W2603502286 citedByCount "98" @default.
• W2603502286 countsByYear W26035022862018 @default.
• W2603502286 countsByYear W26035022862019 @default.
• W2603502286 countsByYear W26035022862020 @default.
• W2603502286 countsByYear W26035022862021 @default.
• W2603502286 countsByYear W26035022862022 @default.
• W2603502286 countsByYear W26035022862023 @default.
• W2603502286 crossrefType "journal-article" @default.
• W2603502286 hasAuthorship W2603502286A5004807660 @default.
• W2603502286 hasAuthorship W2603502286A5018431544 @default.
• W2603502286 hasAuthorship W2603502286A5019195799 @default.
• W2603502286 hasAuthorship W2603502286A5022484621 @default.
• W2603502286 hasAuthorship W2603502286A5023958825 @default.
• W2603502286 hasAuthorship W2603502286A5024182187 @default.
• W2603502286 hasAuthorship W2603502286A5027196488 @default.
• W2603502286 hasAuthorship W2603502286A5027695992 @default.
• W2603502286 hasAuthorship W2603502286A5031469873 @default.
• W2603502286 hasAuthorship W2603502286A5035029873 @default.
• W2603502286 hasAuthorship W2603502286A5055874956 @default.
• W2603502286 hasAuthorship W2603502286A5060490064 @default.
• W2603502286 hasAuthorship W2603502286A5068157865 @default.
• W2603502286 hasAuthorship W2603502286A5070035943 @default.
• W2603502286 hasAuthorship W2603502286A5074699709 @default.
• W2603502286 hasAuthorship W2603502286A5081646000 @default.
• W2603502286 hasBestOaLocation W26035022861 @default.
• W2603502286 hasConcept C126322002 @default.
• W2603502286 hasConcept C141071460 @default.
• W2603502286 hasConcept C2776301958 @default.
• W2603502286 hasConcept C2777214474 @default.
• W2603502286 hasConcept C2778810321 @default.
• W2603502286 hasConcept C2779161974 @default.
• W2603502286 hasConcept C2780290652 @default.
• W2603502286 hasConcept C2909255381 @default.
• W2603502286 hasConcept C42219234 @default.
• W2603502286 hasConcept C71924100 @default.
• W2603502286 hasConcept C90924648 @default.
• W2603502286 hasConceptScore W2603502286C126322002 @default.
• W2603502286 hasConceptScore W2603502286C141071460 @default.
• W2603502286 hasConceptScore W2603502286C2776301958 @default.
• W2603502286 hasConceptScore W2603502286C2777214474 @default.
• W2603502286 hasConceptScore W2603502286C2778810321 @default.
• W2603502286 hasConceptScore W2603502286C2779161974 @default.
• W2603502286 hasConceptScore W2603502286C2780290652 @default.
• W2603502286 hasConceptScore W2603502286C2909255381 @default.

• next